One Year After FDA’s CBD Public Hearing, Limited Clinical Data Available to Inform Further Federal Guidance for Consumer Safety
Click here to view the PDF.
One Year Later, More Remains on the Agenda for Cannabidiol (CBD)
top of page
bottom of page
One Year After FDA’s CBD Public Hearing, Limited Clinical Data Available to Inform Further Federal Guidance for Consumer Safety
Click here to view the PDF.